AbbVie said that the heavily-advertised drug was now approved for four conditions across different so-called “immune-mediated” inflammatory diseases.
Source link
AbbVie said that the heavily-advertised drug was now approved for four conditions across different so-called “immune-mediated” inflammatory diseases.
Source link
Protect your digital identity with Hogo. Hogo scans for exposed personally identifiable information and identifies risky data brokers, helping you stay one step ahead in data privacy. Learn how to protect your sensitive information Check out Hogo's blog to learn how you can protect your personally identifiable information. Empower yourself with knowledge and tools to keep your personal information safe and private.
